Cogent Biosciences, Inc.COGTNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank40
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P40
Within normal range
vs 5Y Ago
-2x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025-27.66%
2024-33.21%
2023-24.64%
2022-107.50%
2021-68.71%
202013.71%
2019-25.76%
2018-23.52%
2017-21.87%
2016-239.59%